Welcome to LookChem.com Sign In|Join Free
  • or
7-Bromo-2-methyl-4-quinolinol, also known as broxyquinoline, is a chemical compound belonging to the quinolinol family with the molecular formula C10H8BrNO. It is recognized for its antifungal and biocidal properties, making it a versatile agent in various industrial and agricultural applications. Due to its ability to inhibit fungal growth, it is also considered for use in pharmaceutical and polymer industries. As a moderately hazardous chemical, it requires careful handling and appropriate safety measures.

56716-92-8

Post Buying Request

56716-92-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56716-92-8 Usage

Uses

Used in Antifungal Applications:
7-BROMO-2-METHYL-4-QUINOLINOL is used as an antifungal agent for its ability to inhibit the growth of various fungi, which is crucial in preventing fungal infections and contamination in different settings.
Used in Biocidal Applications:
In the biocidal industry, 7-BROMO-2-METHYL-4-QUINOLINOL is used as a biocide to control and eliminate harmful microorganisms, ensuring cleanliness and safety in various environments.
Used in Industrial Applications:
7-BROMO-2-METHYL-4-QUINOLINOL is used as a corrosion inhibitor in the industrial sector to protect materials from corrosion, thereby extending their lifespan and maintaining structural integrity.
Used in Agricultural Applications:
In agriculture, 7-BROMO-2-METHYL-4-QUINOLINOL is used as a fungicide to protect crops from fungal diseases, ensuring higher yields and better crop quality.
Used in Pharmaceutical Industry:
7-BROMO-2-METHYL-4-QUINOLINOL is used as a potential pharmaceutical agent due to its antifungal properties, which can be harnessed in the development of medications for treating fungal infections.
Used in Polymer Industry:
In the polymer industry, 7-BROMO-2-METHYL-4-QUINOLINOL is used for its potential applications in enhancing the properties of polymers, such as improving their resistance to fungal degradation.

Check Digit Verification of cas no

The CAS Registry Mumber 56716-92-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,7,1 and 6 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 56716-92:
(7*5)+(6*6)+(5*7)+(4*1)+(3*6)+(2*9)+(1*2)=148
148 % 10 = 8
So 56716-92-8 is a valid CAS Registry Number.
InChI:InChI=1/C10H8BrNO/c1-6-4-10(13)8-3-2-7(11)5-9(8)12-6/h2-5H,1H3,(H,12,13)

56716-92-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (BBO000273)  7-Bromo-4-hydroxy-2-methylquinoline  AldrichCPR

  • 56716-92-8

  • BBO000273-1G

  • 2,575.17CNY

  • Detail

56716-92-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-bromo-2-methyl-1H-quinolin-4-one

1.2 Other means of identification

Product number -
Other names 7-BROMO-2-METHYL-4-QUINOLINOL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56716-92-8 SDS

56716-92-8Relevant academic research and scientific papers

CHEMICAL COMPOUNDS

-

Page/Page column 163, (2013/07/05)

The invention is directed to substituted quinoline derivatives. Specifically, the invention is directed to compounds according to Formula I: wherein R, R1, R2, R3 and R4 are defined herein. The compounds of the invention are inhibitors of lactate dehydrogenase A and can be useful in the treatment of cancer and diseases associated with tumor cell metabolism, such as cancer, and more specifically cancers of the breast, colon, prostate and lung. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting lactate dehydrogenase A activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 56716-92-8